Best Agrolife Ltd

Q3 FY26Fertilizers & Agrochemicals

Best Agrolife Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹18

Market cap₹743 Cr

P/E25.1

Updated23 Aug 2026

Read4 min read

The short version

Company expects growth to resume from next year after stabilizing inventory and working capital. - Projected revenue for FY 2026 is Rs. Revenue is expected to grow to Rs.

From Best Agrolife Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Company expects growth to resume from next year after stabilizing inventory and working capital.
Projected revenue for FY 2026 is Rs. 1,300 to Rs. 1,400 crore, with sales growth anticipated in FY 2027 to Rs. 1,600 - 1,800 crore.
Over next two years, revenue expected to exceed past peak levels, driven by patented products.
Operating profit margin (OPM) target for FY 2027 is around 16-17%, with a long-term goal up to 20%.
Existing production capacity sufficient to support Rs. 2,000+ crore revenue without additional CAPEX.
Growth fueled by expanding patented portfolio and new product launches, with improved sales team and policies.
Export business and international expansion seen as a significant growth driver over time.
Management confident worst sales and EBITDA margin decline are behind, expecting upward trajectory going forward.

Profitability & Margins

Revenue is expected to grow to Rs. 1,600-1,800 crores by FY 2027-28, recovering from the current lower base.
Operating profit margins (EBITDA) are targeted at 16%-17% minimum in the next two years, potentially reaching 20% in longer term.
The worst financial performance is considered behind; growth and profitability improvements expected starting June 2026.
New patented products launched recently are anticipated to drive revenue and profitability growth in the coming years.
Current capacity can support Rs. 2,000+ crore revenue without additional CAPEX, indicating scalability.
Cost rationalization on inventory, OPEX, and sales returns has improved EBITDA despite revenue pressures.
Earnings per share (EPS) likely to improve in line with revenue and EBITDA growth but was under pressure due to recent challenges.
Management is confident of returning to strong growth and profitability trajectory by FY 2027.

See what Best Agrolife Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Currently, there is no active CAPEX being undertaken ("So, for CAPEX, we are not doing anything as of now" - Vikas Jain, Page 17).
The CAPEX plan depends on receiving the balance 75% amount from preferential allotment. Only the initial 25% amount received was used for working capital (Page 17).
The company plans to reassess the CAPEX decision "four, five months down the line" and is currently keeping CAPEX on hold (Page 16).
Existing capacity is sufficient to achieve revenues beyond Rs. 1,800 crore without adding new capacity (Page 9).
Any future strategic investments, such as international expansion and new product registrations, are underway but not quantified as specific capital investments yet (Page 9).
Focus remains on stabilizing operations, inventory, and working capital before considering fresh investments (Page 17).

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech &₹180 Cr

Rev 2Mar 1

2Dharmaj Crop Guard Ltd₹911 Cr

Rev 2Mar 2

3₹5.6K Cr

Rev 2Mar 3

4₹1.3K Cr

Rev 3Mar 1

5₹56.9K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company has received 25% of the preferential issue amount, which has been utilized for working capital.
The remaining 75% of the preferential amount, planned primarily for CAPEX (new plant), has not yet been received.
Currently, there are no active plans for fund-raising through promoters or institutions for CAPEX, as the company has sufficient capacity for the next two years.
The company is monitoring the market situation before deciding on actions regarding the balance 75% installment or alternative funding.
If the pending preferential funds are not received, the company may consider external funding in the future, but no commitment or immediate plan exists as of now.

See what Best Agrolife Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Best Agrolife Limited. However, insights related to sales and order environment include: - The company faced lower sales in the current year due to unseasonal rainfall and market conditions but expects recovery starting June next year. - Inventory and sales return issues have been stabilized with stringent policies, aiding better dealer and sales team comfort. - New patented products such as BestMan and Fetagen have shown strong acceptance with over 4 lakh treated acres. - The company expects growth driven by these patented products and improved operational stability. - Export shipments continue on a cash basis with ongoing dossiers in international markets. - Capacity is adequate to handle revenues exceeding Rs. 2,000 crore without expansion. - Overall, growth in order flow is anticipated from FY 2027 onwards with better market conditions and product portfolio strength. No specific numeric order book or pending order values were disclosed.

Best Agrolife Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹156 Cr, net loss ₹37 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Best Agrolife's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Indogulf Cropsci (Q3 FY26)
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…
Rallis India Ltd (Q3 FY26)
Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness. Key concall takeaways from Rallis India's Q3 FY26…
Sharda Cropchem Ltd (Q3 FY26)
Capex planned in the range of INR 450-500 crores to support growth and registration activities. Key concall takeaways from Sharda Cropchem Ltd's Q3 FY26…
Krishana Phoschem Ltd (Q3 FY26)
It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Key concall takeaways from Krishana…

Compare:vs Coromandel International Ltd vs F A C T vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Best Agrolife Ltd Q3 FY26 results?

Company expects growth to resume from next year after stabilizing inventory and working capital. - Projected revenue for FY 2026 is Rs. Revenue is expected to grow to Rs.

What is Best Agrolife Ltd share price analysis?

Best Agrolife Ltd currently shows a neutral. The stock trades at a P/E of 25.1 with a market cap of ₹743 Cr. Investors should review the full earnings analysis for detailed insights.

Is Best Agrolife Ltd planning capital expenditure?

Currently, there is no active CAPEX being undertaken ("So, for CAPEX, we are not doing anything as of now" - Vikas Jain, Page 17). - The CAPEX plan depends on receiving the balance 75% amount from preferential allotment.

Keep Best Agrolife Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.